Recorlev (levoketoconazole), Strongbridge Biopharma's oral investigational therapy for endogenous Cushing's syndrome, resulted in sustained improvements in cortisol and glycemic control in patients with Cushing...
Loading...
November 21, 2021 by Georgann Nugent and filed under Alternative Medicine / Health, News and Public Affairs, Nutrition.
Join Dr. Fred while talking about...